abstract |
A compound of the formula (I) is provided which is an inhibitor of the kinase family of the p38 mitogen activated protein, and its use in treatment, included in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including diseases. inflammatory lungs such as asthma and COPD. |